Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M308261200 on September 3, 2003

J. Biol. Chem., Vol. 278, Issue 47, 46927-46937, November 21, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/47/46927    most recent
M308261200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crimeen-Irwin, B.
Right arrow Articles by Russell, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crimeen-Irwin, B.
Right arrow Articles by Russell, S. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ligand Binding Determines Whether CD46 Is Internalized by Clathrin-coated Pits or Macropinocytosis*

Blessing Crimeen-Irwin{ddagger}§, Sarah Ellis{ddagger}, Dale Christiansen¶||**, Mandy J. Ludford-Menting{ddagger}, Julie Milland¶, Marc Lanteri¶, Bruce E. Loveland¶, Denis Gerlier||, and Sarah M. Russell{ddagger}{ddagger}{ddagger}

From the {ddagger}Peter MacCallum Cancer Centre, Trescowthick Research Laboratories, St. Andrew's Place, East Melbourne, Victoria 3002, Australia, The Austin Research Institute, Austin Health, Studley Road, Heidelberg, Victoria 3084, Australia, and ||Immunity et Infections Virales, Institut Fédératif Laennec, CNRS-UCBL UMR5537, 69372 Lyon Cedex 08, France

CD46 is a ubiquitous human cell surface receptor for the complement components C3b and C4b and for various pathogens, including the measles virus and human herpes virus 6. Ligand binding to CD46 affects (i) protection of autologous cells from complement attack by breakdown of complement components, (ii) intracellular signals that affect the regulation of immune cell function, (iii) antigen presentation, and (iv) down-regulation of cell surface CD46. Recent evidence indicates that CD46 signaling can link innate and acquired immune function. The molecular mechanisms for these processes and the importance of intracellular trafficking of the receptor have not yet been elucidated. We demonstrate here that, in nonlymphoid cells, CD46 is constitutively internalized via clathrin-coated pits, traffics to multivesicular bodies, and is recycled to the cell surface. However, cross-linking of CD46 at the cell surface, by either multivalent antibody or by measles virus, induces pseudopodia that engulf the ligand in a process similar to macropinocytosis, and leads to the degradation of cell surface CD46. Thus, we have elucidated two pathways for CD46 internalization, which are regulated by the valence of cross-linking of CD46 and which utilize either clathrin-coated pits or pseudopodial extension. This has important implications for CD46 signaling, antigen presentation, CD46 down-regulation, and engulfment of pathogens.


Received for publication, July 29, 2003 , and in revised form, August 29, 2003.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by an Australian Postgraduate Research Award.

** Supported by a National Health and Medical Research Council Howard Florey Centenary Research Fellowship.

{ddagger}{ddagger} Supported by a Wellcome Senior Research Fellowship in Medical Research. To whom correspondence should be addressed. Tel.: 613-9656-3727; Fax: 613-9656-1411; E-mail: sarah.russell{at}petermac.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
C. J. Fang, V. Fremeaux-Bacchi, M. K. Liszewski, G. Pianetti, M. Noris, T. H. J. Goodship, and J. P. Atkinson
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
Blood, January 15, 2008; 111(2): 624 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Iacobelli-Martinez and G. R. Nemerow
Preferential Activation of Toll-Like Receptor Nine by CD46-Utilizing Adenoviruses
J. Virol., February 1, 2007; 81(3): 1305 - 1312.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Oliaro, A. Pasam, N. J. Waterhouse, K. A. Browne, M. J. Ludford-Menting, J. A. Trapani, and S. M. Russell
Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation
PNAS, December 5, 2006; 103(49): 18685 - 18690.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Ludlow, S. McQuaid, S. L. Cosby, R. Cattaneo, B. K. Rima, and W. P. Duprex
Measles virus superinfection immunity and receptor redistribution in persistently infected NT2 cells
J. Gen. Virol., August 1, 2005; 86(8): 2291 - 2303.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement